Search for Clinical Trial Results
AML With Myelodysplasia-related Features - 28 Studies Found
Status | Study |
Terminated |
Study Name: Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission Condition:
Interventions: Drug: bortezomib Given SC Other Names: |
Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
Interventions: |
Completed |
Study Name: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition:
Interventions: |
Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
Interventions: |
Completed |
Study Name: Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia Condition:
Interventions: |
Completed |
Study Name: Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes Condition:
Interventions: |
Completed |
Study Name: Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia Condition:
Interventions: |
Completed |
Study Name: Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
Interventions: |
Active, not recruiting |
Study Name: Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission Condition:
Interventions: |
Completed |
Study Name: Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condition:
Interventions: |